ArticleOncotarget2022

Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like tyrosine kinase 3 with venetoclax plus azacitidine in an acute myeloid leukemia xenograft mouse model.

Hirofumi Tsuzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.